Related Experiment Video
Updated: May 19, 2026
10:09
Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
Oncogenic extracellular vesicles in brain tumor progression.
Esterina D'Asti1, Delphine Garnier, Tae H Lee
1Pediatrics, Cancer and Angiogenesis Laboratory, RI MUHC, Montreal Children's Hospital, McGill University Montreal, QC, Canada.
Frontiers in Physiology
|August 31, 2012
Summary
Extracellular vesicles (EVs) are key in brain tumor communication, transporting molecules that influence cancer. These tumor-derived EVs (oncosomes) can be analyzed for brain tumor biomarkers and therapeutic insights.
Area of Science:
- Neuro-oncology
- Cellular Biology
- Biochemistry
Background:
- Brain tumors are challenging due to their unique microenvironment and cellular interactions.
- Extracellular vesicles (EVs) mediate intercellular communication by trafficking molecules.
- Tumor cells release EVs (oncosomes) carrying cancer-promoting molecules.
Purpose of the Study:
- To explore the role of EVs in brain tumor biology and intercellular communication.
- To investigate the potential of EVs as biomarkers for brain malignancies.
Main Methods:
- Analysis of molecular cargo within tumor-derived EVs.
- Investigation of EV biogenesis and uptake mechanisms.
- Postulation of EVs as circulating biomarkers in cerebrospinal fluid (CSF) and blood.
Main Results:
- EVs transport oncogenic proteins (e.g., EGFRvIII), tumor suppressors (e.g., PTEN), and microRNAs (oncomirs).
- EV cargo can alter recipient cell properties and impact the tumor microenvironment.
- Circulating EVs may reflect molecular features, therapy responses, and subtypes of brain tumors.
Conclusions:
- EVs are crucial mediators of intercellular communication in the brain tumor microenvironment.
- Tumor-derived EVs represent a novel platform for developing molecular biomarkers in neuro-oncology.
- EV analysis holds promise for deciphering tumor characteristics and guiding treatment strategies.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:38Intralumenal Vesicles and Multivesicular Bodies
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...